Compare PGY & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGY | QDEL |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | United States |
| Employees | 511 | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 2022 |
| Metric | PGY | QDEL |
|---|---|---|
| Price | $12.73 | $11.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | ★ $34.50 | $28.25 |
| AVG Volume (30 Days) | ★ 3.5M | 2.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $14.27 | $3.51 |
| Revenue Next Year | $14.39 | $3.86 |
| P/E Ratio | $13.54 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.40 | $9.92 |
| 52 Week High | $44.99 | $35.58 |
| Indicator | PGY | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 47.70 |
| Support Level | $10.78 | $10.39 |
| Resistance Level | $15.57 | $12.85 |
| Average True Range (ATR) | 0.89 | 0.95 |
| MACD | -0.21 | 0.34 |
| Stochastic Oscillator | 12.12 | 70.14 |
Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.